P0DTC2 (SPIKE_SARS2) Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)

Spike glycoprotein UniProtKBInterProInteractive Modelling

1273 aa; Sequence (Fasta) ; 2 identical sequences: Severe acute respiratory syndrome coronavirus 2: A0A679G9E9, A0A6G7K2L4

Available Structures

1316 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
SARS-CoV-2 Omicron variant spike protein with two XGv347 binding to two open state RBDs Heteromer
14-1162
15×NAG;NAG; 29×NAG;
Assess
SARS-CoV-2 Omicron variant spike protein with three XGv347 Fabs binding to three closed state RBDs Heteromer
14-1162
16×NAG;NAG; 31×NAG;
Assess
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv289 Heteromer
14-1162
15×NAG;NAG; 27×NAG;
Assess
SARS-CoV-2 Omicron variant spike protein in complex with two XGv347 binding to one close state RBD … Heteromer
14-1162
15×NAG;NAG; 29×NAG;
Assess
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv282 Heteromer
14-1162
16×NAG;NAG; 27×NAG;
Assess
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv265 Heteromer
14-1162
14×NAG;NAG; 26×NAG;
Assess
Neutral Omicron Spike Trimer in complex with ACE2 Heteromer
Q9BYF1;
14-1162
16×NAG;NAG; 34×NAG;
Assess
Cryo-EM structure of the SARS-CoV-2 spike protein (2-up RBD) bound to neutralizing nanobodies P86 Heteromer
14-1162
17×NAG;NAG;NAG; 30×NAG;
Assess
SARS-CoV-2 Omicron variant spike in complex with Fab XGv264 Heteromer
14-1162
36×NAG;
Assess
SARS-CoV-2 Omicron variant spike in complex with Fab XGv051 Heteromer
14-1162
15×NAG;NAG; 30×NAG;
Assess
SARS-CoV-2 Omicron variant spike in complex with Fab XGv286 Heteromer
14-1162
12×NAG;NAG; 28×NAG;
Assess
Three RBD-down state of SARS-CoV-2 D614G spike in complex with the SP1-77 neutralizing antibody Fab… Heteromer
14-1162
NAG; 24×NAG;NAG; 21×NAG;
Assess
One RBD-up state of SARS-CoV-2 D614G spike in complex with the SP1-77 neutralizing antibody Fab fra… Heteromer
14-1162
16×NAG; 12×NAG;NAG; 23×NAG;
Assess
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C3 state Heteromer
Q9BYF1;
14-1161
Assess
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C1 state Heteromer
Q9BYF1;
14-1161
Assess
SARS-CoV-2 Beta spike in complex with two S5D2 Fabs Heteromer
14-1161
Assess
SARS-CoV-2 Beta spike in complex with three S3H3 Fabs Heteromer
14-1161
Assess
SARS-CoV-2 Beta spike in complex with three S5D2 Fabs Heteromer
14-1161
Assess
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2A state Heteromer
Q9BYF1;
14-1161
Assess
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2B state Heteromer
Q9BYF1;
14-1161
Assess
SARS-CoV-2 Beta spike in complex with one S5D2 Fab Heteromer
14-1161
Assess
SARS-CoV-2 Beta spike in complex with two S3H3 Fabs Heteromer
14-1161
Assess
Camel nanobodies 7A3 and 8A2 broadly neutralize SARS-CoV-2 variants Heteromer
15-1159
Assess
Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody B1-182.1 that targets t… Heteromer
14-1149
13×NAG;NAG; 27×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets t… Heteromer
14-1149
NAG; 15×NAG;NAG; 27×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 spike in complex with antibodies B1-182.1 and A19-61.1 Heteromer
14-1149
NAG; 25×NAG;
Assess
SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-S21F2 Heteromer
14-1149
NAG; 22×NAG;
Assess
Beta-06 fab in complex with SARS-CoV-2 beta-Spike glycoprotein Heteromer
13-1147
12×NAG; 28×NAG;
Assess
Beta-43 fab in complex with SARS-CoV-2 beta-Spike glycoprotein Heteromer
13-1147
12×NAG; 29×NAG;
Assess
COVOX-222 fab in complex with SARS-CoV-2 beta-Spike glycoprotein Heteromer
13-1147
12×NAG; 28×NAG;
Assess
OMI-2 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN Heteromer
13-1147
12×NAG; 30×NAG;
Assess
OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE Heteromer
13-1147
12×NAG; 28×NAG;
Assess
OMI-42 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN Heteromer
13-1147
12×NAG; 30×NAG;
Assess
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-8 Heteromer
13-1147
NAG;NAG;NAG;NAG;NAG;NAG;NAG; 32×NAG;AH2;
Assess
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34 Heteromer
13-1147
Assess
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to Fab ab1 (class 1) Heteromer
14-1147
18×NAG; 24×NAG;
Assess
SARS-CoV-2 Omicron closed state spike protein in complex with S3H3 Fab Heteromer
14-1147
Assess
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to Fab ab1 (class 2) Heteromer
14-1147
18×NAG; 24×NAG;
Assess
Complex of SARS-CoV-2 spike protein and Fab P17 with one RBD in open state and two RBD in closed st… Heteromer
14-1147
14×NAG; 16×NAG;
Assess
P17-H014 Fab cocktail in complex with SARS-CoV-2 spike protein Heteromer
14-1147
15×NAG; 16×NAG;
Assess
S-2H2-F3b structure, three RBDs are up and each RBD binds with a 2H2 Fab. Heteromer
14-1147
Assess
SARS-CoV-2 spike proteins trimer in complex with P17 and FC05 Fabs cocktail Heteromer
14-1147
15×NAG; 16×NAG;
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417N mutant spike protein ectodomain bound t… Heteromer
Q9BYF1;
14-1147
18×NAG; 42×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein in complex with human ACE2 Heteromer
Q9BYF1;
14-1147
18×NAG; 26×NAG;
Assess
S-3C1-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 3C1 fab. Heteromer
14-1147
Assess
EM structure of SARS-CoV-2 Spike glycoprotein (one RBD up) in complex with COVOX-159 Heteromer
14-1147
15×NAG; 24×NAG;
Assess
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to VH ab8 Heteromer
14-1147
18×NAG; 24×NAG;
Assess
SARS-CoV-2 S-ACE2 complex Heteromer
Q9BYF1;
14-1147
18×NAG; 36×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein in complex with human ACE2 Heteromer
Q9BYF1;
14-1147
18×NAG; 26×NAG;
Assess
SARS-CoV-2 Delta S-8D3 Heteromer
14-1147
Assess
S-2H2-F1 structure, one RBD is up and two RBDs are down, only up RBD binds with a 2H2 Fab Heteromer
14-1147
Assess
Cryo-EM structure of Omicron S-ACE2, C2 state Heteromer
Q9BYF1;
14-1147
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain bound to huma… Heteromer
Q9BYF1;
14-1147
18×NAG; 26×NAG;
Assess
SARS-CoV-2 Delta S-ACE2-C2b Heteromer
Q9BYF1;
14-1147
Assess
SARS-CoV-2 spike protein and P17 fab complex with one RBD in close state Heteromer
14-1147
27×NAG;
Assess
Cryo-EM structure of neutralizing antibody 1-57 in complex with prefusion SARS-CoV-2 spike glycopro… Heteromer
14-1147
NAG; 18×NAG; 30×NAG;
Assess
SARS-CoV-2 Spike Proteins Trimer in Complex with FC05 and H014 Fabs Cocktail Heteromer
14-1147
15×NAG; 16×NAG;
Assess
SARS-CoV-2 Spike protein in complex with hb27 and fc05 Fab cocktail Heteromer
14-1147
14×NAG;
Assess
S-3C1-F2 structure, two RBDs are up and one RBD is down, the two up RBD bind with a 3C1 fab. Heteromer
14-1147
Assess
S-2H2-F2 structure, two RBDs are up and one RBD is down, each up RBD binds with a 2H2 Fab. Heteromer
14-1147
Assess
S-3C1-F3b structure, all the three RBDs are in the up conformation and each of them associates with… Heteromer
14-1147
Assess
SARS-CoV-2 Delta S-ACE2-C3 Heteromer
Q9BYF1;
14-1147
Assess
EM structure of SARS-CoV-2 Spike glycoprotein (all RBD down) in complex with COVOX-159 Heteromer
14-1147
15×NAG; 24×NAG;
Assess
SARS-CoV-2 Kappa variant spike protein in complex with ACE2, state C2a Heteromer
Q9BYF1;
14-1147
Assess
Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain bound to human ACE2 ectod… Heteromer
Q9BYF1;
14-1147
18×NAG; 26×NAG;
Assess
SARS-CoV-2 Delta S-ACE2-C2a Heteromer
Q9BYF1;
14-1147
Assess
Cryo-EM structure of NTD-directed neutralizing antibody 5-24 in complex with prefusion SARS-CoV-2 s… Heteromer
14-1147
16×NAG;NAG; 36×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 Omicron Spike protein with human ACE2 receptor, C3 state Heteromer
Q9BYF1;
14-1147
Assess
XG005-bound SARS-CoV-2 S Heteromer
14-1147
45×NAG;
Assess
Structure of the SARS-CoV-2 spike glycoprotein in complex with the 87G7 antibody Fab fragment Heteromer
14-1147
12×NAG; 27×NAG;
Assess
S-2H2-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 2H2 Fab. Heteromer
14-1147
Assess
Cryo-EM structure of SARS-CoV-2 Omicron spike protein with ACE2, C1 state Heteromer
Q9BYF1;
14-1147
Assess
Cryo-EM structure of NTD-directed neutralizing antibody 4-8 Fab in complex with SARS-CoV-2 S2P spike Heteromer
14-1147
28×NAG;
Assess
Cryo-EM structure of NTD-directed neutralizing antibody 1-87 in complex with prefusion SARS-CoV-2 s… Heteromer
14-1147
17×NAG;NAG; 34×NAG;
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2… Heteromer
Q9BYF1;
14-1147
18×NAG; 28×NAG;
Assess
Cryo-EM structure of NTD-directed neutralizing antibody 2-17 Fab in complex with SARS-CoV-2 S2P spi… Heteromer
14-1147
26×NAG;
Assess
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to human ACE2 ectod… Heteromer
Q9BYF1;
14-1147
18×NAG; 32×NAG;
Assess
S-3C1-F1 structure, one RBD is up and two RBDs are down, the up RBD binds with a 3C1 fab Heteromer
14-1147
Assess
SARS-CoV-2 Delta S-ACE2-C1 Heteromer
Q9BYF1;
14-1147
Assess
Cryo-EM structure of SARS-CoV-2 Omicron Spike protein with human ACE2 receptor, C2 state Heteromer
Q9BYF1;
14-1147
Assess
Cryo-EM structure of NTD-directed neutralizing antibody 4-18 in complex with prefusion SARS-CoV-2 s… Heteromer
14-1147
24×NAG; 30×NAG;
Assess
SARS-CoV-2 Omicron open state spike protein in complex with S3H3 Fab Heteromer
14-1147
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain bound t… Heteromer
Q9BYF1;
14-1147
18×NAG; 28×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2 Heteromer
Q9BYF1;
14-1147
18×NAG; 34×NAG;
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2… Heteromer
Q9BYF1;
14-1147
18×NAG; 28×NAG;
Assess
The state 1 complex structure of Omicron spike with Bn03 (1-up RBD, 3 nanobodies) Heteromer
14-1147
40×NAG;
Assess
The state 3 complex structure of Omicron spike with Bn03 (2-up RBD, 5 nanobodies) Heteromer
14-1147
28×NAG;
Assess
The state 2 complex structure of Omicron spike with Bn03 (2-up RBD, 4 nanobodies) Heteromer
14-1147
36×NAG;
Assess
Cryo-EM structure of NTD-directed neutralizing antibody LP5 Fab in complex with SARS-CoV-2 S2P spike Heteromer
14-1147
NAG;NAG;NAG; 28×NAG;
Assess
Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutat… Heteromer
14-1147
14×NAG; 10×NAG;
Assess
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development Heteromer
Q9BYF1;
14-1147
14×NAG; 20×NAG;
Assess
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development Heteromer
14-1147
14×NAG; 10×NAG;
Assess
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development Heteromer
Q9BYF1;
14-1147
14×NAG; 12×NAG;
Assess
SARS-CoV-2 Spike in complex with IgG 553-15 (S-553-15 dimer trimer ) Heteromer
14-1147
90×NAG;
Assess
SARS-CoV-2 Spike in complex with IgG 553-60 (1-up trimer) Heteromer
14-1147
39×NAG;
Assess
Omicron Spike bitrimer with 6m6 antibody Heteromer
14-1147
49×NAG;
Assess
SARS-CoV-2 Spike in complex with IgG 553-60 (2-up trimer) Heteromer
14-1147
38×NAG;
Assess
SARS-CoV-2 Spike in complex with IgG 553-15 (S-553-15 trimer) Heteromer
14-1147
45×NAG;
Assess
CC6.30 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (non-uniform refinemen… Heteromer
14-1147
10×NAG; 20×NAG;
Assess
CC6.33 IgG in complex with SARS-CoV-2-6P-Mut7 S protein (non-uniform refinement) Heteromer
14-1147
NAG;NAG; 29×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with human ACE2 Heteromer
Q9BYF1;
14-1147
18×NAG; 36×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with human ACE2 Heteromer
Q9BYF1;
14-1147
18×NAG; 26×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodo… Heteromer
Q9BYF1;
14-1147
23×NAG; 24×NAG;ZN;
Assess
Cryo-EM structure of SARS-CoV-2 D614G spike protein in complex with VH ab6 Heteromer
14-1147
18×NAG; 21×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with human ACE2 Heteromer
Q9BYF1;
14-1147
18×NAG; 42×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein in complex with human ACE2 Heteromer
Q9BYF1;
14-1147
18×NAG; 28×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with VH ab6 Heteromer
14-1147
18×NAG; 23×NAG;
Assess
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutat… Heteromer
Q9BYF1;
14-1147
15×NAG; 33×NAG;ZN;
Assess
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodo… Heteromer
Q9BYF1;
14-1147
22×NAG; 23×NAG;ZN;
Assess
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with S309 fab Heteromer
14-1147
19×NAG; 25×NAG;
Assess
Furin Site deletion of SARS-CoV-2 spike Heteromer
14-1147
Assess
Cryo-EM structure of RBD-directed neutralizing antibody P2B4 in complex with prefusion SARS-CoV-2 s… Heteromer
14-1147
44×NAG;
Assess
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 2 YB9-258 Fabs (2 RBD up) Heteromer
14-1147
12×NAG; 30×NAG;
Assess
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 3 YB13-292 Fabs (1 RBD up) Heteromer
14-1147
12×NAG; 30×NAG;
Assess
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 3 YB13-292 Fabs (2 RBD up) Heteromer
14-1147
12×NAG; 30×NAG;
Assess
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 3 YB13-292 Fabs (3 RBD down) Heteromer
14-1147
12×NAG; 30×NAG;
Assess
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 1 YB9-258 Fab (1 RBD up) Heteromer
14-1147
12×NAG; 30×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with Fab 4A8 Heteromer
14-1147
18×NAG; 21×NAG;
Assess
Nanobody C5 bound to Spike Heteromer
14-1147
15×NAG; 36×NAG;
Assess
SARS-CoV-2 S trimer with four-antibody cocktail complex Heteromer
14-1147
12×NAG;
Assess
SARS-CoV-2 S trimer with three-antibody cocktail complex Heteromer
14-1147
15×NAG;
Assess
SARS-CoV-2 Kappa variant spike protein in C3 state Heteromer
Q9BYF1;
14-1147
Assess
SARS-CoV-2 Kappa variant spike protein in C2b state Heteromer
Q9BYF1;
14-1147
Assess
VAS5 Spike (1 RBD up) Heteromer
14-1147
13×NAG; 31×NAG;
Assess
SARS-CoV-2 spike in complex with the S304 neutralizing antibody Fab fragment Heteromer
15-1147
12×NAG;NAG; 36×NAG;
Assess
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Anticlockwise Direction Heteromer
Q9BYF1;
14-1146
Assess
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting … Heteromer
Q9BYF1;
14-1146
37×NAG; 13×NAG;
Assess
SARS-CoV-2 S-6P in complex with 9 Fabs Heteromer
14-1146
Assess
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme… Heteromer
Q9BYF1;
14-1146
30×NAG; 29×NAG;
Assess
SARS-CoV-2 Omicron Variant SPIKE trimer complexed with ACE2 Heteromer
Q9BYF1;
15-1147
12×NAG; 21×NAG;CL;ZN;
Assess
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing nanobodies (Ty1) Heteromer
14-1146
12×NAG; 39×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting … Heteromer
Q9BYF1;
14-1146
43×NAG; 14×NAG;
Assess
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23) 2-up confor… Heteromer
14-1146
NAG; 45×NAG;
Assess
SARS-CoV-2 spike glycoprotein:Fab 5A6 complex I Heteromer
14-1146
23×NAG;
Assess
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound Heteromer
Q9BYF1;
14-1146
23×NAG;ZN;
Assess
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-014 Heteromer
14-1146
Assess
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme… Heteromer
Q9BYF1;
14-1146
29×NAG; 26×NAG;
Assess
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab H4 Heteromer
14-1146
NAG; 33×NAG;
Assess
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23) Heteromer
14-1146
NAG; 45×NAG;
Assess
SARS-CoV-2 spike in complex with nanobodies E Heteromer
14-1146
51×NAG;
Assess
Beta-26 fab in complex with SARS-CoV-2 beta-Spike glycoprotein Heteromer
15-1147
13×NAG; 31×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting … Heteromer
Q9BYF1;
14-1146
38×NAG; 16×NAG;
Assess
SARS-CoV-2 Spike Glycoprotein with 2 ACE2 Bound Heteromer
Q9BYF1;
14-1146
Assess
Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113… Heteromer
14-1146
20×NAG;NAG; 21×NAG;
Assess
SARS-CoV-2 spike glycoprotein:Fab 3D11 complex Heteromer
14-1146
Assess
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme… Heteromer
Q9BYF1;
14-1146
30×NAG;NAG; 19×NAG;
Assess
SARS-CoV-2 Kappa variant spike protein in complex wth ACE2, state C1 Heteromer
Q9BYF1;
14-1146
Assess
Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351) in complex with Angiotensin-converting enz… Heteromer
Q9BYF1;
14-1146
31×NAG; 17×NAG;
Assess
CryoEm structure of SARS-CoV-2 spike protein (S-6P, 1-up) in complex with sybodies (Sb45) Heteromer
14-1146
19×NAG; 35×NAG;
Assess
S protein of SARS-CoV-2 in complex bound with 4A8 Heteromer
14-1146
NAG; 23×NAG; 25×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting … Heteromer
Q9BYF1;
14-1146
37×NAG; 15×NAG;
Assess
SARS-CoV-2 Spike Glycoprotein with 3 ACE2 Bound Heteromer
Q9BYF1;
14-1146
Assess
SARS-CoV-2 Spike (dimers) in complex with six Fu2 nanobodies Heteromer
14-1146
NAG; 46×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 spike in complex with non-neutralizing NTD-directed CV3-13 Fab isol… Heteromer
15-1147
NAG; 36×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting … Heteromer
Q9BYF1;
14-1146
31×NAG; 13×NAG;
Assess
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Clockwise Direction Heteromer
Q9BYF1;
14-1146
Assess
Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113… Heteromer
14-1146
NAG; 12×NAG; 18×NAG;
Assess
Trimeric SARS-CoV-2 spike ectodomain bound to P008_056 Fab Heteromer
14-1146
25×NAG;BLA; 29×NAG;
Assess
SARS-CoV-spike bound to two neutralising nanobodies Heteromer
14-1146
NAG; 42×NAG;
Assess
S protein of SARS-CoV-2 in complex with 2G1 Heteromer
14-1146
24×NAG; 30×NAG;EIC;
Assess
CryoEM structure of SARS-CoV-2 spike protein (S-6P, 2-up) in complex with sybodies (Sb45) Heteromer
14-1146
17×NAG; 30×NAG;
Assess
SARS-CoV-2 Spike in complex with PVI.V6-14 Fab Heteromer
14-1146
15×NAG;NAG;NAG;NAG; 18×NAG;
Assess
J08 fragment antigen binding in complex with SARS-CoV-2-6P-Mut2 S protein (conformation 1) Heteromer
15-1147
NAG; 15×NAG;
Assess
J08 fragment antigen binding in complex with SARS-CoV-2-6P-Mut2 S protein (conformation 2) Heteromer
15-1147
12×NAG; 21×NAG;
Assess
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development Heteromer
15-1147
18×NAG; 30×NAG;
Assess
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development Heteromer
15-1147
18×NAG; 30×NAG;
Assess
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development Heteromer
15-1147
15×NAG; 24×NAG;
Assess
The SARS-CoV-2 spike in complex with the 1.29 neutralizing nanobody Heteromer
14-1146
NAG; 33×NAG;
Assess
The SARS-CoV-2 spike in complex with the 2.15 neutralizing nanobody Heteromer
14-1146
NAG; 33×NAG;
Assess
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-23 Heteromer
15-1147
Assess
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-57 Heteromer
15-1147
30×NAG;
Assess
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-22 Heteromer
15-1147
Assess
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-45 Heteromer
15-1147
Assess
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-65 Heteromer
15-1147
Assess
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-67 Heteromer
15-1147
14×NAG;NAG;NAG; 32×NAG;
Assess
CryoEM structure of del68-76/del679-688 prefusion-stabilized spike in complex with the Fab of N12-9 Heteromer
14-1146
10×NAG; 28×NAG;
Assess
SARS-CoV-2 Spike (6P) in complex with 2 R1-32 Fabs Heteromer
14-1146
NAG; 24×NAG;
Assess
SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2 Heteromer
Q9BYF1;
14-1146
NAG; 36×NAG;ZN;
Assess
SARS-CoV-2 Spike (6P) in complex with 1 R1-32 Fab Heteromer
14-1146
NAG; 24×NAG;
Assess
SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs Heteromer
14-1146
NAG; 24×NAG;
Assess
The SARS-CoV-2 spike in complex with the 1.10 neutralizing nanobody Heteromer
14-1146
NAG; 33×NAG;
Assess
Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113… Heteromer
14-1146
16×NAG; 20×NAG;
Assess
SARS-CoV-2 Spike in complex with neutralizing Fab SARS2-57 (three down conformation) Heteromer
14-1146
28×NAG; 25×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 spike in complex with FSR22, an anti-SARS-CoV-2 DARPin Heteromer
14-1146
NAG;NAG;NAG; 18×NAG;
Assess
SARS-CoV-2 wildtype spike trimer (6P) in complex with 3 YB9-258 Fabs and 3 R1-32 Fabs (3 RBD up) Heteromer
14-1146
12×NAG; 30×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 Omicron BA.1 spike protein in complex with mouse ACE2 Heteromer
Q8R0I0;
15-1147
22×NAG; 23×NAG;ZN;
Assess
SARS-CoV-2 S B.1.1.529 Omicron variant + S309 + S2L20 Global Refinement Heteromer
14-1145
NAG; 50×NAG;
Assess
SARS-CoV-2 S B.1.617.1 kappa variant + S309 + S2L20 Global Refinement Heteromer
14-1145
51×NAG;
Assess
SARS-CoV-2 S B.1.617.2 delta variant + S2M11 + S2L20 Global Refinement Heteromer
14-1145
NAG; 45×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 Omicron spike in complex with antibodies A19-46.1 and B1-182.1 Heteromer
14-1145
13×NAG; 15×NAG;
Assess
Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C15… Heteromer
14-1145
12×NAG; 35×NAG;
Assess
SARS-CoV-2 S/S2M11/S2M28 Global Refinement Heteromer
14-1145
NAG;NAG; 45×NAG;
Assess
Cryo-EM structure of NTD-directed neutralizing antibody 5-7 in complex with prefusion SARS-CoV-2 sp… Heteromer
14-1145
NAG; 48×NAG;
Assess
SARS-CoV-2 S/S2M11/S2X333 Global Refinement Heteromer
14-1145
NAG;NAG; 45×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 Omicron spike in complex with antibody A19-46.1 Heteromer
14-1145
14×NAG; 28×NAG;
Assess
SARS-CoV-2 S B.1.617.1 kappa variant + S2X303 Global Refinement Heteromer
14-1145
NAG; 51×NAG;
Assess
SARS-CoV-2 Omicron BA.1 spike ectodomain trimer in complex with the S2X324 neutralizing antibody Fa… Heteromer
14-1145
NAG; 48×NAG;
Assess
Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of huma… Heteromer
15-1145
29×NAG; 25×NAG;
Assess
Structure of the SARS-CoV-2 Spike trimer with three RBDs up in complex with the Fab fragment of hum… Heteromer
15-1145
33×NAG; 21×NAG;
Assess
SARS-CoV-2 S/S2M11/S2L28 Global Refinement Heteromer
14-1144
NAG;NAG;NAG; 39×NAG;
Assess
SARS-CoV-2 BA.2 variant spike protein in complex with Fab BD55-5840 Heteromer
22-1150
Assess
SARS-CoV-2 S Omicron Spike B.1.1.529 - 3-P2G3 and 1-P5C3 Fabs (Global) Heteromer
19-1147
14×NAG;NAG;NAG; 26×NAG;
Assess
Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with two RBDs down in complex with the Fab … Heteromer
19-1147
27×NAG; 19×NAG;
Assess
Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with one RBD down in complex with the Fab f… Heteromer
19-1147
20×NAG; 23×NAG;
Assess
CryoEM structure of neutralizing nanobody Nb12 in complex with SARS-CoV2 spike Heteromer
23-1150
NAG; 13×NAG; 22×NAG;
Assess
SARS-CoV-2 Omicron-BA.2 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations… Heteromer
20-1147
10×NAG; 27×NAG;
Assess
cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, three RBDs bound Heteromer
14-1140
21×NAG;NAG; 18×NAG;
Assess
Beta-50 fab in complex with SARS-CoV-2 beta-Spike glycoprotein Heteromer
21-1147
NAG; 14×NAG;NAG; 25×NAG;
Assess
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C548 Heteromer
15-1140
NAG;NAG;NAG;NAG; 26×NAG;
Assess
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting no… Heteromer
23-1148
Assess
SARS-CoV-2 spike in complex with the S2M11 neutralizing antibody Fab fragment Heteromer
15-1140
18×NAG;NAG; 30×NAG;
Assess
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C051 Heteromer
15-1140
NAG; 27×NAG;
Assess
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragmen… Heteromer
15-1140
NAG; 32×NAG;
Assess
Beta049 fab in complex with SARS-CoV2 beta-Spike glycoprotein, The Beta mAb response underscores th… Heteromer
22-1147
NAG; 14×NAG;NAG; 26×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with Fab S2M11 Heteromer
15-1140
18×NAG;NAG; 30×NAG;
Assess
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-3 Heteromer
22-1147
NAG; 45×NAG;
Assess
cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, two RBDs bound Heteromer
14-1138
NAG;NAG; 25×NAG;
Assess
Omicron spike trimer with 6m6 antibody Heteromer
23-1147
24×NAG;
Assess
Cryo-EM structure of double ACE2-bound SARS-CoV-2 trimer Spike at pH 7.4 Heteromer
Q9BYF1;
26-1149
NAG; 53×NAG;
Assess
SARS-CoV-2 spike protein in complex with sybodyb#15 in a 1up/1up-out/1down conformation. Heteromer
26-1149
NAG;NAG;NAG;NAG; 19×NAG;
Assess
Cryo-EM structure of triple ACE2-bound SARS-CoV-2 trimer spike at pH 7.4 Heteromer
Q9BYF1;
26-1149
NAG; 55×NAG;
Assess
Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5 Heteromer
Q9BYF1;
26-1149
NAG; 48×NAG;
Assess
SARS-CoV-2 spike protein in complex with sybody#68 in a 2up/1flexible conformation Heteromer
26-1149
10×NAG;NAG;NAG;NAG; 28×NAG;
Assess
SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 3up conformation Heteromer
26-1149
10×NAG;NAG;NAG;NAG; 29×NAG;
Assess
SARS-CoV-2 spike in complex with LCB1 (2RBDs open) Heteromer
27-1150
13×NAG; 33×NAG;
Assess
Cryo-EM structure of Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 5.5 Heteromer
Q9BYF1;
26-1149
NAG; 56×NAG;
Assess
Cryo-EM structure of broadly neutralizing antibody 2-36 in complex with prefusion SARS-CoV-2 spike … Heteromer
24-1147
16×NAG;NAG;
Assess
SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 1up/1up-out/1down conformation Heteromer
26-1149
11×NAG;NAG;NAG; 19×NAG;
Assess
SARS-CoV-2 spike protein in complex with Fab 15033-7, 3-"up", asymmetric Heteromer
14-1137
NAG;NAG;NAG;
Assess
3D model of the 3-RBD up single trimeric spike protein of SARS-CoV2 in the presence of synthetic pe… Heteromer
26-1149
39×NAG;
Assess
CryoEM structure of neutralizing nanobody Nb30 in complex with SARS-CoV2 spike Heteromer
26-1149
11×NAG;NAG;NAG; 29×NAG;
Assess
SARS-CoV-2 spike protein in complex with Fab 15033-7, 2-"up"-1-"down" conformation Heteromer
14-1137
12×NAG;NAG; 16×NAG;
Assess
SARS-CoV-2 S (Spike Glycoprotein) D614G with Three (3) RBDs Up, Bound to Antibody 2-7 scFv, composi… Heteromer
26-1149
NAG; 45×NAG;
Assess
The state 5 of Omicron Spike with bispecific antibody FD01 Heteromer
24-1147
18×NAG;
Assess
The state 4 of Omicron Spike with bispecific antibody FD01 Heteromer
24-1147
23×NAG;
Assess
The state 2 of Omicron Spike with bispecific antibody FD01 Heteromer
24-1147
23×NAG;
Assess
The state 3 of Omicron Spike with bispecific antibody FD01 Heteromer
24-1147
21×NAG;
Assess
The state 1 of Omicron Spike with bispecific antibody FD01 Heteromer
24-1147
28×NAG;
Assess
The state 6 of Omicron Spike with bispecific antibody FD01 Heteromer
24-1147
Assess
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 5.5 Heteromer
Q9BYF1;
26-1148
NAG; 44×NAG;
Assess
SARS-CoV-2 S trimer with one RBD in the open state and complexed with one H014 Fab. Heteromer
25-1147
15×NAG; 30×NAG;
Assess
SARS-CoV-2 S trimer with two RBDs in the open state and complexed with two H014 Fab Heteromer
25-1147
15×NAG; 30×NAG;
Assess
CryoEM structure of SARS-CoV-2 Spike in complex with Nb17 Heteromer
25-1147
Assess
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 7.4 Heteromer
Q9BYF1;
26-1148
NAG; 46×NAG;
Assess
Complex of SARS-CoV-2 spike trimer with its neutralizing antibody HB27 Heteromer
25-1147
15×NAG; 29×NAG;
Assess
SARS-CoV-2 S trimer with three RBD in the open state and complexed with three H014 Fab Heteromer
25-1147
15×NAG; 30×NAG;
Assess
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34 Heteromer
25-1147
12×NAG; 50×NAG;
Assess
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state1) Heteromer
Q9BYF1;
22-1144
NAG;ZN;CL; 49×NAG;
Assess
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2) Heteromer
Q9BYF1;
22-1144
NAG; 53×NAG;ZN;CL;
Assess
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state1) Heteromer
22-1144
NAG;NAG; 45×NAG;
Assess
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state2) Heteromer
22-1144
NAG;NAG; 45×NAG;
Assess
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state3) Heteromer
22-1144
NAG; 45×NAG;
Assess
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting no… Heteromer
27-1148
Assess
SARS-CoV-2 spike in prefusion state Heteromer
27-1148
16×NAG;NAG;NAG; 18×NAG;MAN;DMS;
Assess
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H4 Q98R H100E nanobody complex in 2Up1Down conformation Heteromer
26-1147
20×NAG; 26×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 spike glycoprotein in complex with three F61 Fab Heteromer
26-1147
24×NAG;
Assess
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-34 Heteromer
26-1147
42×NAG;
Assess
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-28 Heteromer
26-1147
39×NAG;
Assess
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, HSW-1 Heteromer
26-1147
NAG; 34×NAG;
Assess
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-31 Heteromer
26-1147
NAG; 39×NAG;
Assess
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-40 Fab Heteromer
27-1147
11×NAG; 27×NAG;
Assess
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-40 Fab Heteromer
27-1147
11×NAG; 27×NAG;
Assess
SARS-CoV-2 Spike in complex with neutralizing nanobody Nb6 Heteromer
27-1147
12×NAG; 30×NAG;
Assess
SARS-CoV-2 Spike in complex with neutralizing nanobody mNb6 Heteromer
27-1147
18×NAG; 27×NAG;
Assess
SARS-CoV-2 Spike in complex with neutralizing Fab SARS2-38 (three down conformation) Heteromer
27-1147
15×NAG; 33×NAG;
Assess
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragmen… Heteromer
27-1147
NAG;NAG;NAG; 26×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound to two copies of domain-swapped antibody 2G12 Heteromer
27-1147
NAG;NAG;NAG;NAG; 25×NAG;
Assess
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-88 Fab Heteromer
27-1147
15×NAG;NAG;NAG; 30×NAG;
Assess
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the M1 conformation, D4 Heteromer
27-1147
12×NAG; 22×NAG;
Assess
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(1 out RBD, state3) Heteromer
27-1147
27×NAG;
Assess
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragmen… Heteromer
27-1147
NAG;NAG;
Assess
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragmen… Heteromer
27-1147
10×NAG; 21×NAG;
Assess
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-253H165L Fab Heteromer
27-1147
10×NAG;NAG; 27×NAG;
Assess
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting no… Heteromer
27-1147
Assess
Cryo-EM structure of prefusion SARS-CoV-2 spike glycoprotein in complex with 910-30 Fab Heteromer
27-1147
12×NAG; 35×NAG;
Assess
SARS-CoV-2 Spike Protein Trimer bound to DH1043 fab Heteromer
27-1147
Assess
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragmen… Heteromer
27-1147
28×NAG;
Assess
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(3 up RBDs, state2) Heteromer
27-1147
27×NAG;
Assess
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragmen… Heteromer
27-1147
15×NAG; 27×NAG;
Assess
SARS-CoV-2 Spike Glycoprotein with two ACE2 Bound Heteromer
Q9BYF1;
27-1147
20×NAG; 40×NAG;
Assess
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragmen… Heteromer
27-1147
15×NAG; 30×NAG;
Assess
Spike protein from SARS-CoV2 with Fab fragment of enhancing antibody 8D2 Heteromer
27-1147
Assess
EM structure of SARS-CoV-2 Spike glycoprotein (one RBD up) in complex with COVOX-253H55L Fab Heteromer
27-1147
10×NAG;NAG; 27×NAG;
Assess
Structure of the SARS-CoV-2 spike glycoprotein in complex with the 47D11 neutralizing antibody Fab … Heteromer
27-1147
10×NAG;NAG;NAG;NAG;NAG;MAN; 28×NAG;FUC;MAN;
Assess
SARS CoV2 Spike ectodomain with engineered trimerized VH binder Heteromer
27-1147
Assess
Cryo-EM structure of South African (B.1.351) SARS-CoV-2 spike glycoprotein in complex with three T6… Heteromer
27-1147
25×NAG;
Assess
SARS-CoV-2 Spike in complex with neutralizing Fab 2H04 (three down conformation) Heteromer
27-1147
12×NAG; 21×NAG;NAG;NAG;NAG;NAG;
Assess
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7) in complex with Angiotensin-converting enzym… Heteromer
Q9BYF1;
27-1147
29×NAG; 26×NAG;
Assess
Mink Cluster 5-associated SARS-CoV-2 spike protein(S-GSAS-D614G-delFV) missing the S1 subunit and S… Heteromer
27-1147
NAG; 27×NAG;
Assess
SARS-CoV-2 Spike Glycoprotein with three ACE2 Bound Heteromer
Q9BYF1;
27-1147
24×NAG; 42×NAG;
Assess
Spike protein from SARS-CoV2 with Fab fragment of enhancing antibody 2490 Heteromer
27-1147
Assess
SARS-CoV-2 Spike in complex with Fab of m31A7 Heteromer
20-1140
NAG;NAG;NAG;NAG;NAG;NAG;NAG;NAG;NAG; 19×NAG;
Assess
EM structure of SARS-CoV-2 Spike glycoprotein (all RBD down) in complex with COVOX-253H55L Fab Heteromer
27-1147
14×NAG;NAG; 32×NAG;
Assess
Structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1041 Heteromer
27-1147
11×NAG;NAG; 17×NAG;
Assess
Cryo-EM Structure of SARS-CoV-2 Spike : H11-D4 Nanobody Complex Heteromer
27-1147
20×NAG; 26×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound domain-swapped antibody 2G12 from masked 3D r… Heteromer
27-1147
10×NAG;NAG;NAG;NAG; 32×NAG;
Assess
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-316 Fab Heteromer
27-1147
15×NAG;NAG; 25×NAG;
Assess
Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab f… Heteromer
27-1147
NAG;NAG;NAG;NAG; 30×NAG;
Assess
Beta-53 fab in complex with SARS-CoV-2 beta-Spike glycoprotein Heteromer
27-1147
NAG; 11×NAG; 15×NAG;
Assess
SARS-CoV-2 B.1.1.7 S-ACE2 complex Heteromer
Q9BYF1;
27-1147
16×NAG; 27×NAG;
Assess
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(1 down RBD, state1) Heteromer
27-1147
27×NAG;
Assess
Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab f… Heteromer
27-1147
NAG;NAG;NAG; 24×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound to one copy of domain-swapped antibody 2G12 Heteromer
27-1147
10×NAG;NAG;NAG;NAG; 31×NAG;
Assess
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragmen… Heteromer
27-1147
45×NAG;
Assess
SARS-CoV-2 Spike ectodomain with Fab FI3A Heteromer
27-1147
11×NAG; 27×NAG;
Assess
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragmen… Heteromer
27-1147
13×NAG;NAG;NAG; 33×NAG;
Assess
SARS-CoV-2 Spike in complex with neutralizing Fab 2B04 (one up, two down conformation) Heteromer
27-1147
14×NAG; 21×NAG;NAG;NAG;NAG;
Assess
SARS-CoV-2 Spike glycoprotein in complex with a neutralizing antibody EY6A Fab Heteromer
27-1147
13×NAG; 23×NAG;
Assess
SARS-CoV-2 Spike Glycoprotein with one ACE2 Bound Heteromer
Q9BYF1;
27-1147
17×NAG; 36×NAG;
Assess
Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutat… Heteromer
27-1147
22×NAG;
Assess
Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutat… Heteromer
27-1147
20×NAG;
Assess
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-384 Fab Heteromer
27-1147
15×NAG; 30×NAG;
Assess
Cryo-EM structure of South African (B.1.351) SARS-CoV-2 spike glycoprotein in complex with two T6 F… Heteromer
27-1147
25×NAG;
Assess
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-150 Fab Heteromer
27-1147
11×NAG; 27×NAG;
Assess
Structure of human SARS-CoV-2 spike glycoprotein trimer bound by neutralizing antibody C1C-A3 Fab (… Heteromer
27-1147
NAG; 45×NAG;
Assess
Beta-32 fab in complex with SARS-CoV-2 beta-Spike glycoprotein Heteromer
27-1147
15×NAG; 30×NAG;
Assess
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragmen… Heteromer
27-1147
13×NAG; 34×NAG;
Assess
J08 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (conformation 3) Heteromer
27-1147
NAG; 16×NAG;
Assess
Cryo-EM structure of the Omicron S in complex with 35B5 Fab(1 down- and 2 up RBDs) Heteromer
27-1147
NAG; 27×NAG;
Assess
Cryo-EM structure of the Omicron S in complex with 35B5 Fab(1 down-, 1 up- and 1 invisible RBDs) Heteromer
27-1147
27×NAG;
Assess
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H6 nanobody complex Heteromer
27-1147
20×NAG; 26×NAG;
Assess
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-B5 nanobody complex Heteromer
27-1147
20×NAG; 26×NAG;
Assess
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H4 Q98R H100E nanobody complex in 1Up2Down conformation Heteromer
27-1147
20×NAG; 26×NAG;
Assess
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11 nanobody complex Heteromer
27-1147
19×NAG; 28×NAG;
Assess
SARS-Cov2 Omicron varient S protein structure in complex with neutralizing monoclonal antibody 002-… Heteromer
27-1147
13×NAG; 28×NAG;
Assess
SARS-CoV-2 Spike protein in complex with the single chain fragment scFv76 Heteromer
27-1147
12×NAG; 27×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 spike glycoprotein in complex with three D2 Fab Heteromer
26-1146
32×NAG;
Assess
Structure of the SARS-CoV-2 Omicron BA.1 S 6P trimer in complex with the mouse antibody Fab fragmen… Heteromer
27-1147
NAG; 27×NAG;
Assess
SARS-CoV-2 Delta Spike in complex with IS-9A Heteromer
27-1147
NAG; 24×NAG;
Assess
Structure of SARS-CoV-2 S protein in complex with N-terminal domain antibody DH1052 Heteromer
27-1147
14×NAG; 31×NAG;
Assess
Structure of SARS-CoV-2 S protein in complex with N-terminal domain antibody DH1050.1 Heteromer
27-1147
15×NAG; 33×NAG;
Assess
Structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1047 Heteromer
27-1147
13×NAG;NAG; 24×NAG;
Assess
CryoEM structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1042 Heteromer
27-1147
NAG; 12×NAG; 33×NAG;
Assess
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-A10 nanobody complex Heteromer
27-1147
20×NAG; 26×NAG;
Assess
H11-H4 bound to Spike Heteromer
27-1147
20×NAG; 26×NAG;
Assess
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragmen… Heteromer
27-1147
28×NAG;
Assess
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragmen… Heteromer
27-1147
23×NAG;
Assess
SARS-CoV-2 spike in complex with LCB3 (2RBDs open) Heteromer
27-1146
13×NAG; 33×NAG;
Assess
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (1 up RBD and 1 PD bound) Heteromer
Q9BYF1;
27-1146
26×NAG; 30×NAG;
Assess
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with BD-368-2 Fabs Heteromer
27-1146
NAG; 31×NAG;
Assess
Furin Cleaved Alpha Variant SARS-CoV-2 Spike in complex with 3 ACE2 Heteromer
Q9BYF1;
27-1146
NAG; 48×NAG;ZN;
Assess
S protein of SARS-CoV-2 in complex bound with P36-5D2(state2) Heteromer
27-1146
17×NAG; 28×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 S-D614G variant in complex with neutralizing antibodies, RBD-chAb15… Heteromer
27-1146
27×NAG; 21×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-45 Heteromer
27-1146
24×NAG; 24×NAG;
Assess
S protein of SARS-CoV-2 in complex bound with P5A-3C12_2B Heteromer
27-1146
22×NAG; 26×NAG;
Assess
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with Fab30 Heteromer
27-1146
13×NAG; 27×NAG;
Assess
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragmen… Heteromer
27-1146
33×NAG;
Assess
S protein of SARS-CoV-2 in complex bound with P5A-3C12_1B Heteromer
27-1146
21×NAG; 27×NAG;
Assess
Conformation 1 of S-ACE2-B0AT1 ternary complex Heteromer
Q695T7; Q9BYF1;
27-1146
58×NAG; 64×NAG;LEU;ZN;
Assess
S protein of SARS-CoV-2 in complex bound with P5A-3A1 Heteromer
27-1146
22×NAG; 26×NAG;
Assess
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-017 Heteromer
27-1146
NAG; 19×NAG;
Assess
SARS-CoV 2 Spike Protein bound to LY-CoV555 Heteromer
27-1146
NAG; 16×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-25 Heteromer
27-1146
27×NAG; 21×NAG;
Assess
BD23-Fab in complex with the S ectodomain trimer Heteromer
27-1146
NAG;NAG; 32×NAG;
Assess
S protein of SARS-CoV-2 in complex bound with P5A-2F11_2B Heteromer
A0A5C2G1U0; P01834; P0DP01; V9HW68;
27-1146
21×NAG;NAG; 28×NAG;
Assess
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragmen… Heteromer
27-1146
11×NAG; 26×NAG;
Assess
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (2 up RBD and … Heteromer
Q9BYF1;
27-1146
32×NAG; 29×NAG;
Assess
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C032 Heteromer
27-1146
NAG;NAG; 22×NAG;
Assess
S protein of SARS-CoV-2 in complex bound with T-ACE2 Heteromer
Q9BYF1;
27-1146
35×NAG; 34×NAG;
Assess
SARS-CoV-2 Omicron Variant S Trimer complexed with two JMB2002 Fab Heteromer
27-1146
NAG; 36×NAG;
Assess
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (3 up RBD and … Heteromer
Q9BYF1;
27-1146
32×NAG; 29×NAG;
Assess
SARS-CoV-2 Omicron Variant S Trimer complexed with three JMB2002 Fab Heteromer
27-1146
NAG; 35×NAG;
Assess
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-4 Heteromer
A0A5C2GJG2;
27-1146
NAG;NAG;NAG; 36×NAG;
Assess
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (2 up RBD and 1 PD bound) Heteromer
Q9BYF1;
27-1146
27×NAG; 28×NAG;
Assess
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and … Heteromer
Q9BYF1;
27-1146
27×NAG; 28×NAG;
Assess
S protein of SARS-CoV-2 in complex bound with P36-5D2 (state1) Heteromer
27-1146
Assess
SARS-CoV-2 Omicron Variant S Trimer complexed with one JMB2002 Fab Heteromer
27-1146
NAG; 33×NAG;
Assess
S protein of SARS-CoV-2 in complex bound with P5A-2F11_3B Heteromer
A0A5C2G1U0; P01834; P0DP01; V9HW68;
27-1146
22×NAG;NAG; 27×NAG;
Assess
S protein of SARS-CoV-2 in complex with GW01 Heteromer
27-1146
23×NAG; 25×NAG;
Assess
S protein of Delta variant in complex with ZWD12 Heteromer
27-1146
23×NAG; 25×NAG;
Assess
S protein of Delta variant in complex with ZWC6 Heteromer
27-1146
23×NAG; 25×NAG;
Assess
SARS-CoV-2 Omicron BA.1 Variant Spike Trimer with two mouse ACE2 Bound Heteromer
Q8R0I0;
27-1146
39×NAG;ZN;
Assess
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with one mouse ACE2 Bound Heteromer
Q8R0I0;
27-1146
34×NAG;ZN;
Assess
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two mouse ACE2 Bound Heteromer
Q8R0I0;
27-1146
37×NAG;ZN;
Assess
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with three human ACE2 Bound Heteromer
Q9BYF1;
27-1146
39×NAG;CL;ZN;
Assess
S-ECD (Omicron) in complex with STS165 Heteromer
27-1146
19×NAG; 33×NAG;
Assess
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two human ACE2 Bound Heteromer
Q9BYF1;
27-1146
39×NAG;CL;ZN;
Assess
S-ECD (Omicron) in complex with PD of ACE2 Heteromer
Q9BYF1;
27-1146
23×NAG; 45×NAG;
Assess
SARS-CoV-2 Omicron BA.1 Variant Spike Trimer with one mouse ACE2 Bound Heteromer
Q8R0I0;
27-1146
37×NAG;ZN;
Assess
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with three JMB2002 Fab Bound Heteromer
27-1146
NAG; 35×NAG;
Assess
Cryo EM structure of SARS-CoV-2 spike in complex with TAU-2212 mAbs in conformation 4 Heteromer
27-1146
33×NAG;
Assess
overall structure of hu33 and spike Heteromer
27-1146
NAG; 10×NAG; 26×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 Omicron spike glycoprotein in complex with three F61 Fab and three … Heteromer
27-1146
31×NAG;
Assess
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-6 Heteromer
28-1147
48×NAG;
Assess
SARS-CoV-2 spike in complex with the ZB8 neutralizing antibody Fab (3U) Heteromer
27-1146
18×NAG; 18×NAG;
Assess
S protein of SARS-CoV-2 in complex bound with P5A-1B9 Heteromer
A0A5C2G1U0; P01825; Q6GMX6; Q8TCD0;
27-1146
19×NAG; 33×NAG;
Assess
S protein of SARS-CoV-2 in complex bound with P5A-1B6_2B Heteromer
P01594; P0DOX5; P0DP02; Q8TCD0;
27-1146
21×NAG; 28×NAG;
Assess
SARS-CoV-2 spike in complex with the ZB8 neutralizing antibody Fab (2u1d) Heteromer
27-1146
17×NAG; 20×NAG;
Assess
S protein of SARS-CoV-2 in complex bound with P2B-1A1 Heteromer
A0A5C2GM57; P01825; Q5EFE5; Q8N5F4;
27-1146
23×NAG; 28×NAG;
Assess
S protein of SARS-CoV-2 in complex bound with P5A-1B8_3B Heteromer
A0A5C2GCZ2; A0A5C2GG81; Q6GMX6; Q8TCD0;
27-1146
20×NAG; 31×NAG;
Assess
S protein of SARS-CoV-2 in complex bound with P2B-1A10 Heteromer
A0A5C2GF00; P01594; P0DOX5; Q8TCD0;
27-1146
21×NAG; 28×NAG;
Assess
S protein of SARS-CoV-2 in complex bound with P5A-2G7 Heteromer
A0A0C4DH41; A0A5C2G2G8; Q6IPQ0; V9HW68;
27-1146
21×NAG; 28×NAG;
Assess
S protein of SARS-CoV-2 in complex bound with P5A-1B6_3B Heteromer
P01594; P0DOX5; P0DP02; Q8TCD0;
27-1146
20×NAG; 31×NAG;
Assess
S protein of SARS-CoV-2 in complex bound with P5A-2G9 Heteromer
A0A5C2GMM2; P01772; P0DOX5; Q8N5F4;
27-1146
21×NAG; 28×NAG;
Assess
S protein of SARS-CoV-2 in complex bound with FabP5A-1B8 Heteromer
A0A5C2GCZ2; A0A5C2GF00; Q6GMX6; Q8TCD0;
27-1146
21×NAG; 28×NAG;
Assess
SARS-CoV-2 Omicron BA.1 Spike in complex with IY-2A Heteromer
27-1146
Assess
S protein of SARS-CoV-2 in complex bound with FabP5A-2G7 Heteromer
A0A0C4DH41; A0A5C2G2G8; Q6IPQ0; V9HW68;
27-1146
20×NAG; 29×NAG;
Assess
S protein of SARS-CoV-2 in complex bound with P5A-1B8_2B Heteromer
A0A5C2GCZ2; A0A5C2GG81; Q6GMX6; Q8TCD0;
27-1146
20×NAG; 30×NAG;
Assess
SARS-CoV-2 Spike trimer in complex with XG014 Fab Heteromer
27-1146
24×NAG;
Assess
Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C17… Heteromer
27-1146
NAG;NAG; 27×NAG;
Assess
Structure of SARS-CoV-2 Spike with P5C3 Fab Heteromer
27-1145
Assess
Structure of the SARS-CoV-2 Spike trimer with two RBDs down in complex with the Fab fragment of hum… Heteromer
27-1145
21×NAG; 30×NAG;
Assess
SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment Heteromer
27-1145
12×NAG;NAG; 33×NAG;
Assess
SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 Global Refinement Heteromer
27-1145
NAG;NAG; 39×NAG;
Assess
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (one RBD open) Heteromer
27-1145
11×NAG; 36×NAG;
Assess
Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of huma… Heteromer
27-1145
23×NAG; 28×NAG;
Assess
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C118 (State 1) Heteromer
27-1145
39×NAG;
Assess
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragmen… Heteromer
27-1145
15×NAG; 33×NAG;
Assess
SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment Heteromer
27-1145
15×NAG; 33×NAG;
Assess
Structure of the SARS-CoV-2 Spike trimer with all RBDs down in complex with the Fab fragment of hum… Heteromer
27-1145
21×NAG; 30×NAG;
Assess
SARS-CoV-2 S glycoprotein in complex with S2X259 Fab Heteromer
27-1145
12×NAG; 30×NAG;
Assess
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (closed conformation) Heteromer
27-1145
12×NAG; 36×NAG;
Assess
Structure of the SARS-CoV-2 S 6P trimer in complex with the ACE2 protein decoy, CTC-445.2 (State 4) Heteromer
27-1145
NAG; 27×NAG;
Assess
SARS-CoV-2 spike in complex with AHB2-2GS-SB175 Heteromer
27-1145
12×NAG; 36×NAG;
Assess
P5C3 is a potent fab neutralizer Heteromer
27-1145
Assess
SARS-CoV-2 BA.2.75 S Trimer in complex with XG2v024 Heteromer
22-1140
15×NAG;NAG; 24×NAG;
Assess
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-7 Heteromer
27-1144
NAG; 30×NAG;
Assess
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-15 Heteromer
27-1144
NAG;NAG;NAG; 31×NAG;
Assess
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-43 Heteromer
27-1144
NAG;NAG; 31×NAG;
Assess
SARS-CoV-2 spike in complex with the S2K146 neutralizing antibody Fab fragment (two receptor-bindin… Heteromer
26-1141
NAG; 37×NAG;
Assess
SARS-CoV-2 Delta Spike in complex with FP-12A Heteromer
25-1140
NAG; 21×NAG;
Assess
Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab f… Heteromer
27-1140
12×NAG;NAG; 33×NAG;
Assess
Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab f… Heteromer
27-1140
10×NAG;NAG;NAG; 35×NAG;
Assess
Major cryo-EM structure of S protein trimer of SARS-CoV2 with K-874, composite map Heteromer
27-1138
Assess
Minor cryo-EM structure of S protein trimer of SARS-CoV2 with K-874A VHH, composite map Heteromer
27-1138
Assess
SARS-CoV-2 S Omicron Spike B.1.1.529 - RBD and NTD (Local) Heteromer
19-1061
NAG;NAG;NAG;
Assess
Structure of the SARS-CoV-2 S1 subunit in complex with antibody N-612-004 Heteromer
12-700
Assess
CryoEM structure of SARS-CoV-2 spike monomer in complex with neutralising antibody P008_60 Heteromer
14-697
NAG;3Q9;
Assess
Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Unmasked Refinement) Heteromer
Q9BYF1;
14-676
NAG;NAG;ZN;
Assess
Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2 Heteromer
Q9BYF1;
14-676
ZN;NAG;
Assess
Structure of the SARS-CoV-2 S S1 doamin in complex with the mouse antibody Fab fragment, HSW-2 Heteromer
24-676
NAG;
Assess
Complex of SARS-CoV-2 spike and CR3022 Fab (Homogeneous Refinement) Heteromer
33-676
NAG;
Assess
SARS-CoV-2 wildtype S1 in complex with YB9-258 Fab and R1-32 Fab Heteromer
33-676
NAG;
Assess
SARS-CoV-2 Omicron BA.1 spike trimer (6P) complex with YB9-258 Fab, focused refinement of RBD-dimer… Heteromer
14-588
NAG;
Assess
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with YB9-258 Fab, focused refinement of Fab re… Heteromer
14-588
NAG;
Assess
SARS-CoV-2 spike trimer RBD in complex with Fab NA8 Heteromer
27-590
NAG;
Assess
SARS-CoV-2 spike trimer RBD in complex with Fab NE12 Heteromer
32-590
NAG;
Assess
Complex of SARS-CoV-2 spike and CR3022 Fab (Non-Uniform Refinement) Heteromer
33-579
NAG;
Assess
SARS-CoV-2 Spike (2P) in complex with G32R7 Fab (RBD and NTD local reconstruction) Heteromer
14-528
NAG;NAG;NAG;
Assess
SARS-CoV-2 NTD in complex with N9 Fab Heteromer
14-526
Assess
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab (state1, local refinement of the … Heteromer
27-527
NAG;
Assess
Cryo-EM structure of SARS-CoV-2 spike protein in complex with nanobody C5G2 (localized refinement) Heteromer
27-517
NAG;
Assess
Local CryoEM structure of the SARS-CoV-2 S6PV2 in complex with BD-813 Fab and BD-744 Fab Heteromer
28-516
Assess
Local CryoEM structure of the SARS-CoV-2 S6PV2 in complex with BD-804 Fab Heteromer
28-516
NAG;
Assess
Local CryoEM of the SARS-CoV-2 S6PV2 in complex with BD-667 Heteromer
28-516
NAG;
Assess
Crystal structure of a chimeric protein mimic of SARS-CoV-2 Spike HR1 in complex with HR2 Heteromer
757-1203
Assess
Structure of the SARS-CoV-2 NTD in complex with C1520, local refinement Heteromer
14-322
NAG;NAG;
Assess
Structure of viral peptides IPB19/N52 Heteromer
908-1201
Assess
Crystal structure of the N-terminal domain of SARS-CoV-2 beta variant spike glycoprotein in complex… Heteromer
13-305
NAG;NAG;NAG;CL;PEG;GOL;PO4;NAG;PG4;
Assess
SARS-CoV-2 S NTD B.1.1.529 Omicron variant + S309 Local Refinement Heteromer
14-306
NAG;
Assess
SARS-CoV-2 S NTD B.1.617.2 delta variant + S2L20 Local Refinement Heteromer
14-306
NAG;NAG;
Assess
SARS-CoV-2 S NTD B.1.617.1 kappa variant S2L20 Local Refinement Heteromer
14-306
NAG;NAG;
Assess
Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with Fab 4-8 (focused refineme… Heteromer
14-306
NAG;
Assess
Crystal structure of SARS-CoV-2 S NTD bound to S2M28 Fab Heteromer
14-305
NAG;NAG;NAG;NAG;UNX;XYL;SO4;
Assess
SARS-CoV-2 S NTD B.1.617.1 kappa variant S2X303 Local Refinement Heteromer
14-305
NAG;NAG;
Assess
SARS-CoV-2 Spike NTD in complex with neutralizing Fab SARS2-57 (local refinement) Heteromer
14-304
NAG;NAG;
Assess
Crystallographic structure of neutralizing antibody 2-51 in complex with SARS-CoV-2 spike N-termina… Heteromer
14-303
NAG;NAG; 23×CA;ACT;PGE;
Assess
an engineered 5-helix bundle derived from SARS-CoV-2 S2 in complex with HR2P Heteromer
918-1204
Assess
Structure of the SARS-CoV-2 Omicron spike post-fusion bundle Heteromer
918-1200
Assess
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with A942S mutation Heteromer
918-1200
Assess
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with V1176F mutation Heteromer
918-1200
Assess
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with L938F mutation Heteromer
918-1200
Assess
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with S940F mutation Heteromer
918-1200
Assess
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex Heteromer
918-1200
Assess
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with D936Y mutation Heteromer
918-1200
Assess
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with extended HR2 Heteromer
918-1200
Assess
SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 (Local Refinement of the NTD/S2L20) Heteromer
27-306
NAG;
Assess
Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with Fab 4A8 (focused refineme… Heteromer
14-293
NAG;NAG;
Assess
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with Fab 4A8 (focused refinem… Heteromer
14-293
NAG;NAG;
Assess
SARS-CoV-2 Spike Protein N terminal domain in Complex with N11 Fab Heteromer
13-290
Assess
SARS-CoV-2 Spike in complex with PVI.V6-14 Fab Heteromer
A0A5C2FYK4;
14-291
NAG;NAG;
Assess
A proof of concept for neutralizing antibody-guided vaccine design against SARS-CoV-2 Heteromer
14-290
Assess
SARS-CoV-2 Spike (2P) in complex with C12C9 Fab (NTD local reconstruction) Heteromer
14-290
NAG;
Assess
Local CryoEM structure of del68-76/del679-688 prefusion-stabilized spike in complex with the Fab of… Heteromer
14-290
Assess
SARS-CoV-2 spike in complex with the ZB8 neutralizing antibody Fab (focused refinement on Fab-RBD) Heteromer
317-593
Assess
SARS-CoV-2 Omicron spike protein SD1 in complex with S3H3 Fab Heteromer
318-593
Assess
SARS-CoV-2 Beta spike SD1 in complex with S3H3 Fab Heteromer
318-593
Assess
sd1.040 Fab in complex with SARS-CoV-2 Spike 2P glycoprotein Heteromer
321-591
NAG;
Assess
Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) Heteromer
Q9BYF1;
322-590
ZN;NAG;
Assess
Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) Heteromer
Q9BYF1;
322-590
NAG;NAG;ZN;
Assess
Dissociated S1 domain of Mink Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) Heteromer
Q9BYF1;
322-590
ZN;NAG;
Assess
Cryo-EM structure of SARS-CoV-2 Omicron RBD in complex with S309 fab (local refinement) Heteromer
322-590
NAG;
Assess
Dissociated S1 domain of Beta Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) Heteromer
Q9BYF1;
323-590
NAG;ZN;
Assess
Cryo-EM structure of spike binding to Fab of neutralizing antibody (locally refined) Heteromer
333-590
NAG;
Assess
SARS-CoV-2 S-NTD + Fab CM25 Heteromer
14-270
Assess
Antibody A7V3 bound to N-terminal domain of the spike Heteromer
14-270
NAG;
Assess
SARS-CoV-2 S/S2M11/S2M28 Local Refinement Heteromer
14-267
NAG;NAG;
Assess
SARS-CoV-2 S/S2M11/S2L28 Local Refinement Heteromer
14-265
NAG;NAG;
Assess
OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE RBD (local refinement) Heteromer
323-567
NAG;
Assess
SARS-CoV-2 S/S2M11/S2X333 Local Refinement Heteromer
14-251
NAG;NAG;
Assess
Structure of human SARS-CoV-2 neutralizing antibody C1C-A3 Fab Heteromer
319-541
NAG;NAG;
Assess
Crystallographic structure of two neutralizing nanobodies in complex with SARS-CoV-2 spike receptor… Heteromer
309-529
NAG;NAG;PEG;GOL;
Assess
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development Heteromer
319-536
Assess
Structure of SARS-CoV-2 spike protein receptor binding domain in complex with a neutralizing antibo… Heteromer
321-537
NAG;
Assess
SARS-CoV-2 Spike:5A6 Fab complex I focused refinement Heteromer
329-537
NAG;
Assess
SARS-CoV-2 Spike:Fab 3D11 complex focused refinement Heteromer
329-537
NAG;
Assess
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody… Heteromer
325-532
NAG;
Assess
Structure of SARS-CoV-2 spike protein receptor binding domain in complex with a potent neutralizing… Heteromer
326-532
NAG;
Assess
CC6.33 IgG in complex with SARS-CoV-2-6P-Mut7 S protein (RBD/Fv local refinement) Heteromer
326-532
NAG;NAG;
Assess
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development Heteromer
326-530
NAG;
Assess
immune complex of SARS-CoV-2 RBD and cross-neutralizing antibody 7D6 Heteromer
324-527
NAG;NAG;
Assess
Crystal structure of the SARS-CoV-2 RBD in complex with a human single domain antibody n3113 Heteromer
328-531
NAG;
Assess
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immuni… Heteromer
Q9BYF1;
329-531
NAG;CL;SO4;NA;PG5;ZN;NAG;PGE;
Assess
Structure of sybody SR31 in complex with the SARS-CoV-2 S Receptor Binding domain (RBD) Heteromer
330-531
NAG; 13×FMT;GOL;ACT;
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2… Heteromer
Q9BYF1;
330-530
NAG;
Assess
Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein in complex with human ACE2 (focused… Heteromer
Q9BYF1;
330-530
NAG;
Assess
SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv347 Heteromer
330-530
Assess
Local refinement of SARS-CoV-2 S-Gamma variant (P.1) RBD and Angiotensin-converting enzyme 2 (ACE2)… Heteromer
Q9BYF1;
330-530
NAG;NAG;
Assess
Local refinement of SARS-CoV-2 S-Beta variant (B.1.351) RBD and Angiotensin-converting enzyme 2 (AC… Heteromer
Q9BYF1;
330-530
NAG;NAG;
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain bound to huma… Heteromer
Q9BYF1;
330-530